Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127916611 | 12791661 | 1 | I | 20160906 | 20160919 | 20160929 | 20160929 | EXP | GB-MHRA-EYC 00145258 | GB-TEVA-694963ACC | TEVA | 72.00 | YR | F | Y | 0.00000 | 20160929 | PH | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127916611 | 12791661 | 1 | PS | RAMIPRIL. | RAMIPRIL | 1 | Oral | Y | U | 77470 | 1.25 | MG | |||||||
127916611 | 12791661 | 2 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | Y | U | 0 | 500 | MG | |||||||
127916611 | 12791661 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
127916611 | 12791661 | 4 | C | ATENOLOL. | ATENOLOL | 1 | 0 | ||||||||||||
127916611 | 12791661 | 5 | C | BENDROFLUMETHIAZIDE | BENDROFLUMETHIAZIDE | 1 | 0 | ||||||||||||
127916611 | 12791661 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127916611 | 12791661 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127916611 | 12791661 | Anaphylactic reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127916611 | 12791661 | 1 | 20160817 | 0 | ||
127916611 | 12791661 | 2 | 20160904 | 0 |